Vicinitas Therapeutics
PrivateLast Round
Series A
Jul 28, 2022
Total Funding Raised
$65M
Company Overview
Vicinitas Therapeutics is a biotechnology company that develops novel therapeutics for cancer and genetic disorders using its proprietary Deubiquitinase Targeting Chimeras (DUBTACs) protein stabilization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vicinitas Therapeutics Comparables
Compare Vicinitas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stablix | 93% | |
| Entact Bio | 83% | |
| General Proximity | 73% | |
Vicinitas Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2022 |
Vicinitas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Deerfield Management | Series A |
| GV | Series A |
| Droia Ventures | Series A |
| Berkeley Catalyst Fund | Series A |
| The Mark Foundation for Cancer Research | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2022
$65M round led by Andreessen Horowitz and Deerfield Management.
Vicinitas Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vicinitas Therapeutics's valuation, stock price, and market status.